Data |
Ora |
Fonte |
Titolo |
14/6/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Grant of Options and Restricted Stock Units |
12/6/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Result of AGM |
11/6/2024 | 12:10 | ALNC | IN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares |
11/6/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. PDMR Dealing |
03/6/2024 | 16:22 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
29/5/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. Participation in Upcoming Investor Conference |
29/5/2024 | 14:05 | GLOBE | MaxCyte to Participate in William Blair 44th Annual Growth.. |
22/5/2024 | 22:51 | ALNC | IN BRIEF: MaxCyte inks deal with Legend Biotech for tech.. |
22/5/2024 | 14:05 | GLOBE | MaxCyte Signs Strategic Platform License Agreement with.. |
22/5/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. Signing of Strategic Platform License |
20/5/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
14/5/2024 | 15:55 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
08/5/2024 | 10:46 | ALNC | MaxCyte shares rise amid double-digit revenue increase |
08/5/2024 | 08:05 | LSEG_RNS | MaxCyte, Inc. Filing of Form 10-Q |
08/5/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. First Quarter Results |
07/5/2024 | 22:05 | GLOBE | MaxCyte Reports First Quarter 2024 Financial Results and.. |
03/5/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Notice of AGM |
01/5/2024 | 18:04 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
10/4/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. Notice of Results |
10/4/2024 | 14:05 | GLOBE | MaxCyte to Report First Quarter 2024 Financial Results on.. |
03/4/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights and Block Listing Return |
02/4/2024 | 16:19 | ALNC | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian.. |
02/4/2024 | 14:05 | GLOBE | MaxCyte Signs Strategic Platform License with Be Biopharma.. |
02/4/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. Signing of Strategic Platform License |
02/4/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
20/3/2024 | 11:16 | LSEG_RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR.. |
20/3/2024 | 11:05 | LSEG_RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR.. |
13/3/2024 | 12:54 | ALNC | IN BRIEF: MaxCyte loss widens in 2023 as core revenue.. |
13/3/2024 | 08:05 | LSEG_RNS | MaxCyte, Inc. Filing of form 10-K for FY ended December 31,.. |
13/3/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results |
12/3/2024 | 21:05 | UKREG | MaxCyte Reports Fourth Quarter and Full Year 2023 Financial.. |
06/3/2024 | 09:58 | LSEG_RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
05/3/2024 | 21:43 | ALNC | EARNINGS: dotdigital eyes rosy future; Beeks Financial turns.. |
05/3/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Preliminary FY Results & 2024 Guidance |
04/3/2024 | 22:05 | UKREG | MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023.. |
01/3/2024 | 18:57 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
29/2/2024 | 10:21 | LSEG_RNS | MaxCyte, Inc. Exercise of options and PDMR dealing |
26/2/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
09/2/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. Notice of Results |
09/2/2024 | 14:05 | UKREG | MaxCyte to Report Fourth Quarter and Full Year 2023.. |
01/2/2024 | 10:24 | LSEG_RNS | MaxCyte, Inc. Total Voting Rights |
31/1/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Director/PDMR Shareholding |
30/1/2024 | 15:29 | LSEG_RNS | MaxCyte, Inc. Holding(s) in Company |
30/1/2024 | 14:58 | ALNC | IN BRIEF: MaxCyte signs licencing deal with cell therapy.. |
30/1/2024 | 14:05 | UKREG | MaxCyte and Wugen Sign Strategic Platform License to.. |
30/1/2024 | 14:05 | LSEG_RNS | MaxCyte, Inc. Signing of Strategic Platform License |
29/1/2024 | 18:56 | ALNC | IN BRIEF: MaxCyte chief scientific officer leaves firm |
29/1/2024 | 17:52 | LSEG_RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
29/1/2024 | 08:00 | LSEG_RNS | MaxCyte, Inc. Filing of Form 8-K |
23/1/2024 | 19:39 | ALNC | TRADING UPDATES: Esken's Southend Airport faces further.. |